Výsledky vyhledávání - James G. Christensen

Upřesnit hledání
  1. 1
    An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Reduces Tumor Burden and Metastasis in a Preclinical Model of Ovarian Cancer Metastasis

    An Orally Available Small-Molecule Inhibitor of c-Met, PF-2341066, Reduces Tumor Burden and Metastasis in a Preclinical Model of Ovarian Cancer Metastasis Autor Marion Zillhardt, James G. Christensen, Ernst Lengyel

    Vydáno 2010
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  2. 2
    A Selective Small Molecule c-MET Inhibitor, PHA665752, Cooperates with Rapamycin

    A Selective Small Molecule c-MET Inhibitor, PHA665752, Cooperates with Rapamycin Autor C. Patrick, Erik Schaefer, James G. Christensen, Ravi Salgia

    Vydáno 2005
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  3. 3
    Acquired Resistance of Non–Small Cell Lung Cancer Cells to MET Kinase Inhibition Is Mediated by a Switch to Epidermal Growth Factor Receptor Dependency

    Acquired Resistance of Non–Small Cell Lung Cancer Cells to MET Kinase Inhibition Is Mediated by a Switch to Epidermal Growth Factor Receptor Dependency Autor Ultan McDermott, Raju V. Pusapati, James G. Christensen, Nathanael S. Gray, Jeff Settleman

    Vydáno 2010
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  4. 4
    Targeting Kras <sup>g12c</sup> ‐mutant cancer with a mutation‐specific inhibitor

    Targeting Kras <sup>g12c</sup> ‐mutant cancer with a mutation‐specific inhibitor Autor James G. Christensen, Peter Olson, Tina M. Briere, Clotilde Wiel, Martin O. Bergö

    Vydáno 2020
    Získat plný text Získat plný text
    Revisão
    Přidat do oblíbených
    Uloženo v:
  5. 5
    HGF Rescues Colorectal Cancer Cells from EGFR Inhibition via MET Activation

    HGF Rescues Colorectal Cancer Cells from EGFR Inhibition via MET Activation Autor David Liska, Chin‐Tung Chen, Thomas Bachleitner‐Hofmann, James G. Christensen, Martin R. Weiser

    Vydáno 2010
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  6. 6
    Inhibition of c-Met Reduces Lymphatic Metastasis in RIP-Tag2 Transgenic Mice

    Inhibition of c-Met Reduces Lymphatic Metastasis in RIP-Tag2 Transgenic Mice Autor Barbara Sennino, Toshina Ishiguro‐Oonuma, Brian J. Schriver, James G. Christensen, Donald M. McDonald

    Vydáno 2013
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  7. 7
    Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy

    Multiple circulating proangiogenic factors induced by sunitinib malate are tumor-independent and correlate with antitumor efficacy Autor John M.L. Ebos, Christina R. Lee, James G. Christensen, Anthony J. Mutsaers, Robert S. Kerbel

    Vydáno 2007
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  8. 8
    MET Activation Mediates Resistance to Lapatinib Inhibition of <i>HER2</i>-Amplified Gastric Cancer Cells

    MET Activation Mediates Resistance to Lapatinib Inhibition of <i>HER2</i>-Amplified Gastric Cancer Cells Autor Chin‐Tung Chen, Hyaehwan Kim, David Liska, Sizhi Paul Gao, James G. Christensen, Martin R. Weiser

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  9. 9
    Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab

    Human colon cancer stem cells are enriched by insulin-like growth factor-1 and are sensitive to figitumumab Autor Lori S. Hart, Nathan G. Dolloff, David T. Dicker, Constantinos Koumenis, James G. Christensen, Adda Grimberg, Wafik S. El‐Deiry

    Vydáno 2011
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  10. 10
    Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma

    Antiangiogenic and anti-invasive effects of sunitinib on experimental human glioblastoma Autor Sophie de Boüard, Paulette Herlin, James G. Christensen, Edwige Lemoisson, Pascal Gauduchon, Éric Raymond, Jean‐Sébastien Guillamo

    Vydáno 2007
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  11. 11
    Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis

    Accelerated Metastasis after Short-Term Treatment with a Potent Inhibitor of Tumor Angiogenesis Autor John M.L. Ebos, Christina R. Lee, William Cruz‐Muñoz, Georg A. Bjarnason, James G. Christensen, Robert S. Kerbel

    Vydáno 2009
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  12. 12
    Multiple Mutations and Bypass Mechanisms Can Contribute to Development of Acquired Resistance to MET Inhibitors

    Multiple Mutations and Bypass Mechanisms Can Contribute to Development of Acquired Resistance to MET Inhibitors Autor Jie Qi, Michele McTigue, Andrew M. Rogers, Eugene Lifshits, James G. Christensen, Pasi A. Jänne, Jeffrey A. Engelman

    Vydáno 2011
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  13. 13
    Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells

    Association of constitutively activated hepatocyte growth factor receptor (Met) with resistance to a dual EGFR/Her2 inhibitor in non-small-cell lung cancer cells Autor Seema Agarwal, Cynthia Zerillo, J Kolmakova, James G. Christensen, L N Harris, David L. Rimm, Michael P. DiGiovanna, David F. Stern

    Vydáno 2009
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  14. 14
    Resistance to Irreversible EGF Receptor Tyrosine Kinase Inhibitors through a Multistep Mechanism Involving the IGF1R Pathway

    Resistance to Irreversible EGF Receptor Tyrosine Kinase Inhibitors through a Multistep Mechanism Involving the IGF1R Pathway Autor Alexis B. Cortot, Claire E. Repellin, Takeshi Shimamura, Marzia Capelletti, Kreshnik Zejnullahu, Dalia Ercan, James G. Christensen, Kwok‐Kin Wong, Nathanael S. Gray, Pasi A. Jänne

    Vydáno 2012
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  15. 15
    <i>In Vivo</i> Activity of Combined PI3K/mTOR and MEK Inhibition in a <i>KrasG12D</i>;<i>Pten</i> Deletion Mouse Model of Ovarian Cancer

    <i>In Vivo</i> Activity of Combined PI3K/mTOR and MEK Inhibition in a <i>KrasG12D</i>;<i>Pten</i> Deletion Mouse Model of Ovarian Cancer Autor Kathryn M. Kinross, Daniel V. Brown, Margarete Kleinschmidt, Susan Jackson, James G. Christensen, Carleen Cullinane, Rodney J. Hicks, Ricky W. Johnstone, Grant A. McArthur

    Vydáno 2011
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  16. 16
    Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells

    Anaplastic Lymphoma Kinase (ALK) regulates initiation of transcription of MYCN in neuroblastoma cells Autor Christina Schönherr, Kristina Ruuth, Sattu Kamaraj, C-L Wang, Hong‐Ling Yang, Valérie Combaret, Anna Djos, Tommy Martinsson, James G. Christensen, Ruth H. Palmer, Bengt Hallberg

    Vydáno 2012
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  17. 17
    Synergistic Effect of the γ-Secretase Inhibitor PF-03084014 and Docetaxel in Breast Cancer Models

    Synergistic Effect of the γ-Secretase Inhibitor PF-03084014 and Docetaxel in Breast Cancer Models Autor Cathy C. Zhang, Zhengming Yan, Qing Zong, Douglas D. Fang, Cory L. Painter, Qin Zhang, Enhong Chen, Maruja E. Lira, Annette John-Baptiste, James G. Christensen

    Vydáno 2013
    Získat plný text Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  18. 18
    MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib

    MGMT modulates glioblastoma angiogenesis and response to the tyrosine kinase inhibitor sunitinib Autor Manik Chahal, Yaoxian Xu, David Lesniak, Kathryn Graham, Konrad S. Famulski, James G. Christensen, Manish K. Aghi, Amanda Virtuoso Jacques, David J. Murray, Siham Sabri, Bassam Abdulkarim

    Vydáno 2010
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  19. 19
    HGF/c-Met Acts as an Alternative Angiogenic Pathway in Sunitinib-Resistant Tumors

    HGF/c-Met Acts as an Alternative Angiogenic Pathway in Sunitinib-Resistant Tumors Autor Farbod Shojaei, Joseph H. Lee, Brett H. Simmons, Anthony Wong, Carlos O. Esparza, Pamela A. Plumlee, Junli Feng, Albert Stewart, Dana D. Hu‐Lowe, James G. Christensen

    Vydáno 2010
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:
  20. 20
    The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy

    The class I/IV HDAC inhibitor mocetinostat increases tumor antigen presentation, decreases immune suppressive cell types and augments checkpoint inhibitor therapy Autor David M. Briere, Niranjan Sudhakar, David M. Woods, Jill Hallin, Lars D. Engstrom, Ruth Aranda, Harrah Chiang, Andressa L. Sodré, Peter Olson, Jeffrey S. Weber, James G. Christensen

    Vydáno 2017
    Získat plný text
    Artigo
    Přidat do oblíbených
    Uloženo v:

Vyhledávací nástroje: